But the side effects are the best part!

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

An outfit called the Coalition for Healthcare Communication has petitioned the Food and Drug Administration to change the rules for prescription-drug ads aimed at consumers. According to an Associated Press item (as summarized on the HealthScout Web site), the effect of the change would be “to remove most of the consumer warnings contained in prescription drug ads.” On its own Web site, the coalition (whose members include trade groups like the 4A’s and the Association of National Advertisers) says the current regulations mandate the inclusion of “complicated

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in